For the CORA 2017 timetable, please click here.
Is the microbiome the key for autoimmunity?
Can we manage lupus nephritis without chronic corticosteroids administration?
Are 2010 diagnostic criteria for fibromyalgia better than 1990?
Targeting BAFF/BLyS in SLE: is the glass half-full or half-empty?
Should we treat asymptomatic hyperuricemia?
TNF inhibitors in RA and SpA: are they all the same?
Can we withdraw immunosuppressants in patients with lupus nephritis in remission?
The revenge: Vitamin D supplementation in autoimmune rheumatic diseases
Is ACPA positivity the main driver in RA treatment?
Can we withdraw anticoagulation in patients with APS after seroreversion?
Is undifferentiated Spondyloarthritis a discrete entity?
Biosimilar vs Innovators: are they identical?
Hyaluronic acid in osteoarthritis
Tofaticinib is effective and safe in RA patients
Should we treat congenital heart block with fluorinated corticosteroids?
PET-CT is essential in the diagnosis and follow-up of temporal arteritis
Targeting IL-17 in RA and SpA. Is it equally effective?
Difficult clinical cases discussed by top experts
Pregnancy in autoimmune rheumatic diseases
Non organ-specific autoimmune diseases
New aspects in the treatment of autoimmune diseases
News from the laboratory
Co-morbidity and multimorbidity in ARD